Memphis-based GTx Inc. announced it is moving forward with the second phase of clinical trials for Enobosarm, a drug designed to treat muscle wasting in lung cancer patients.
http://www.bizjournals.com/memphis/news/2013/05/01/gtx-initiates-next-phase-of-cancer.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_38+%28Health+Care+Regulation+Industry+News%29
http://www.bizjournals.com/memphis/news/2013/05/01/gtx-initiates-next-phase-of-cancer.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_38+%28Health+Care+Regulation+Industry+News%29
No comments:
Post a Comment